Sara De Dosso
Sara De Dosso is an expert in Oncology at Ente Ospedaliero Cantonale (Switzerland). Sara De Dosso has authored 61 publications, the most recent in 2026, and is an investigator in 4 clinical trials, 1 of them ongoing. SLR score: 239 (community average: 125). How the SLR is computed.
LeadR Profile
Oncology
Subspecialties: Immunology - Hepatology - Gastroenterology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2016 - 2026
Number : 61
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Fusobacterium nucleatum and response to treatment in colon and rectal cancer: a systematic review. PMID 42435617 — fusobacterium nucleatum, disease-free survival, neoplasms, colon, biomarkers, rectal neoplasms, therapeutics, fusobacterium, colorectal neoplasms | Cancer Treat Rev | 2026 | 0 |
| Transarterial Chemoembolization in Hepatocellular Carcinoma: Lessons from a 10-Year Real-World Retrospective Study. PMID 42326605 — carcinoma, hepatocellular, retrospective studies, therapeutics | J Hepatocell Carcinoma | 2026 | 0 |
| Decoding Immunotherapy Response in Colorectal Cancer: Translational Insights Beyond MSI. PMID 41827785 — microsatellite repeats, neoplasms, biomarkers, immunotherapy, therapeutics, colorectal neoplasms, microsatellite instability, msi-h | Cancers (Basel) | 2026 | 0 |
| Intratumoral microbiota and host genotype cooperatively shape neutrophil cytotoxic functions in colorectal cancer. PMID 41819084 — neoplasms, neutrophils, genotype, colorectal neoplasms, gastrointestinal microbiome, prognosis, microbiota | Cell Host Microbe | 2026 | 0 |
| The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancer. PMID 41785904 — pancreatic neoplasms, neoplasms, adenocarcinoma, liver, therapeutics, wounds and injuries | Lancet Oncol Top journal | 2026 | 0 |
Clinical Studies 4
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Metronidazole as Preoperative Therapy in CRC FusoMetro 001 NCT05748145 — fusobacterium nucleatum, metronidazole, neoplasms, therapeutics, fusobacterium, colorectal neoplasms | Phase 2 | Recruiting | 2023 |
LeadR Networks
Main global connection map